» Articles » PMID: 34076600

Clinical Predictors and Prognostic Role of High Killip Class in Patients with a First Episode of Anterior ST-segment Elevation Acute Myocardial Infarction

Abstract

Aims: Killip classification is a simple and fast clinical tool for risk stratification of patients presenting with acute coronary syndrome (ACS). However, the clinical features and predictors of high Killip class at admission, and its prognostic impact in patients presenting with anterior ST elevation MI (STEMI) as first clinical cardiovascular event are still poorly known. The aim of this study was to identify the predictors of high Killip class and its impact on in-hospital and follow-up outcomes.

Methods: We prospectively enrolled patients with unheralded anterior STEMI because of proximal or mid left anterior descending (LAD) artery categorized according to Killip classification. Patients' characteristics, in-hospital complications and major adverse cardiovascular events (MACEs; composite of all-cause death, heart failure hospitalization and new-onset ACS) at follow-up were collected.

Results: We enrolled 147 patients [age 66.16±13.33, 113 male patients (76.9%)]. Killip class III--IV occurred in 22 (15%) patients. The median duration of follow-up was 12 [6--15.1] months. At multivariate analysis age [hazard ratio 1.137, 95% CI (1.068--1.209), P < 0.001], prehospital cardiac arrest [hazard ratio 12.145, 95% CI (1.710--86.254), P = 0.013] and proximal LAD lesion [hazard ratio 5.066, 95% CI (1.400--18.334), P = 0.013] were predictive of Killip class III--IV at admission. At multivariate analysis, Killip class III--IV was an independent predictor of in-hospital mortality [hazard ratio 7.790, 95% CI (1.024--59.276], P = 0.047 and of MACEs [hazard ratio 4.155 (1.558--11.082), P = 0.004) at follow-up.

Conclusion: Killip classification performed at the time of admission is a simple and useful clinical marker of a high risk of early and late adverse cardiovascular events.

Citing Articles

Performance of the Risk Scores for Predicting In-Hospital Mortality in Patients with Acute Coronary Syndrome in a Chinese Cohort.

Bai L, Li Y, Yang B, Cheng Y, Zhang Y, Liao G Rev Cardiovasc Med. 2024; 24(12):356.

PMID: 39077082 PMC: 11272866. DOI: 10.31083/j.rcm2412356.


Risk factors for ventricular arrhythmias after emergency percutaneous coronary intervention in elderly patients with acute myocardial infarction.

He Y, Liu J, Zhang Y, Tian Y, Li Y, Liu E Am J Transl Res. 2024; 16(5):1678-1689.

PMID: 38883350 PMC: 11170566. DOI: 10.62347/WZNF8280.


Pharmacological inhibition of RUNX1 reduces infarct size after acute myocardial infarction in rats and underlying mechanism revealed by proteomics implicates repressed cathepsin levels.

Chen H, Wang S, Zhang X, Hua X, Liu M, Wang Y Funct Integr Genomics. 2024; 24(3):113.

PMID: 38862712 PMC: 11166773. DOI: 10.1007/s10142-024-01391-2.


Electrocardiogram and echocardiography findings and the outcomes of patients with myocardial infarction: Retrospective study in tertiary care hospitals in Northwest Ethiopia.

Tsega W, Awoke W, Sendekie A, Dagnew E, Bayih H PLoS One. 2023; 18(8):e0288698.

PMID: 37540698 PMC: 10403055. DOI: 10.1371/journal.pone.0288698.


Development and Validation of Nomogram for the Prediction of Malignant Ventricular Arrhythmia Including Circulating Inflammatory Cells in Patients with Acute ST-Segment Elevation Myocardial Infarction.

Wang L, Yang L, Li T, Geng S J Inflamm Res. 2023; 16:3185-3196.

PMID: 37529768 PMC: 10389081. DOI: 10.2147/JIR.S420305.